Delivery Order SPE2DB22D2006-SPE2DB25FW2FP
- Not listed
- The Defense Logistics Agency awarded a $2,954.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for Rhogam Ultra-Filtered Plus syringes, with an ultimate completion date of July 22, 2025. This non-set-aside contract is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...
- The Defense Logistics Agency awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This firm fixed-price contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with performance to be completed by July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a $1,969.36 delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under a larger indefinite delivery contract (IDC) vehicle, leveraging the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes valued at $1,821.20 under a firm fixed price contract. The award was made on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction typical of federal medical procurement operations supporting military and defense healthcare systems. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,481.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOGAM ULTRA-FILTERED PLUS SYRS. The delivery order was issued against an existing prime vendor contract vehicle to supply the specified Rho(D) Immune Globulin product. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 24, 2023 to September 15, 2023. As a leading provider of medical products and services to the...
- This is a $2,360.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product. The delivery order has a firm fixed price of $1,969.36 and a period of performance through May 27, 2025. This order is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2FPDelivery Order
The Defense Logistics Agency awarded a $1,138.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for RHOGAM Ultra-Filtered Plus syringes, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award was issued on July 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RHOGAM is a Rho(D) immune globulin product used to prevent Rh sensitization in Rh-negative pregnant women and other clinical applications. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's history of competitively awarded delivery orders with firm fixed pricing across multiple therapeutic domains demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/5/25 |